Supply Chain

While hospitals are not factories and patients are not cars, health systems can learn valuable logistics lessons from the automotive and retail industries, according to Mark Graban, author of the book Lean Hospitals.

The Food and Drug Administration approved a new product Wednesday to repair cartilage defects in the knee.

Indianapolis-based Eli Lilly unveiled Tuesday a new discount program for its insulin products. Under the program, which begins in January, patients who pay full price for insulin will be able to access a 40 percent discount, reports the Chicago Tribune.

Robotics is one of the fastest-growing trends in logistics right now, with more distribution centers turning to the technology to improve workflows and boost efficiency.

Sioux Falls, S.D.-based MedVantx Pharmacy Services and Pittsburgh-based UPMC Health Plan continue to expand their ongoing partnership to provide free, full-course samples to increase medication adherence.

With 2016 coming to a close, the global drug industry is set to receive the lowest annual amount of new drug approvals from the Food and Drug Administration since 2010, reports Reuters.

The Food and Drug Administration recently approved Synjardy XR, a diabetes medication developed by Indianapolis-based Eli Lilly & Co. and Ridgefield, Conn.-based Boehringer Ingelheim Pharmaceuticals.

The Food and Drug Administration recently approved two new treatments to reduce the severity of nasolabial folds or "laugh lines" in adults.

Biopharmaceutical company JHL Biotech and Sanofi entered into a strategic alliance granting Sanofi exclusive rights to manufacture and market its own proposed biosimilar of JHL Biotech's drug Rituximab in China. Under the contract, JHL Biotech would be entitled to up…

The rising price of the opioid-antidote drug naloxone may hinder national efforts to reduce opioid-related deaths, according to a new report published in The New England Journal of Medicine.